132 related articles for article (PubMed ID: 21505011)
1. Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome.
Laczik R; Szodoray P; Veres K; Szomják E; Csípo I; Sipka S; Shoenfeld Y; Szekanecz Z; Soltész P
Lupus; 2011 Jun; 20(7):730-5. PubMed ID: 21505011
[TBL] [Abstract][Full Text] [Related]
2. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
[TBL] [Abstract][Full Text] [Related]
3. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease.
Soltesz P; Veres K; Laczik R; Der H; Csipo I; Timar O; Szomjak E; Szegedi G; Szodoray P
Thromb Haemost; 2007 Aug; 98(2):413-9. PubMed ID: 17721625
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
[TBL] [Abstract][Full Text] [Related]
6. Adaptive immunity is related to coronary artery disease severity after acute coronary syndrome in subjects with metabolic syndrome.
Izar MC; Fonseca HA; Pinheiro LF; Monteiro CM; Póvoa RM; Monteiro AM; Figueiredo-Neto AM; Gidlund MA; Fonseca FA
Diab Vasc Dis Res; 2013 Jan; 10(1):32-9. PubMed ID: 22529217
[TBL] [Abstract][Full Text] [Related]
7. Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.
Zhao D; Ogawa H; Wang X; Cameron GS; Baty DE; Dlott JS; Triplett DA
Am J Clin Pathol; 2001 Nov; 116(5):760-7. PubMed ID: 11710695
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatment.
Papathanasiou AI; Lourida ES; Tsironis LD; Goudevenos JA; Tselepis AD
Atherosclerosis; 2008 Jan; 196(1):289-297. PubMed ID: 17140582
[TBL] [Abstract][Full Text] [Related]
9. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
Wang JJ; Han AZ; Meng Y; Gong JB; Zhang CN; Li K; Liu YX
Clin Biochem; 2010 Apr; 43(6):571-5. PubMed ID: 20060390
[TBL] [Abstract][Full Text] [Related]
10. A study of IgG antibodies to the ApoB protein in non-ST segment elevation acute coronary syndrome.
Zhang X; Yu B; Jin Y; Lei M; Zhang X; Duan Z; Lin Y; Megson IL; Wei J
Scand Cardiovasc J; 2015 Jun; 49(3):136-41. PubMed ID: 25833671
[TBL] [Abstract][Full Text] [Related]
11. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
[TBL] [Abstract][Full Text] [Related]
12. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
13. Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
Vuilleumier N; Bas S; Pagano S; Montecucco F; Guerne PA; Finckh A; Lovis C; Mach F; Hochstrasser D; Roux-Lombard P; Gabay C
Arthritis Rheum; 2010 Sep; 62(9):2640-50. PubMed ID: 20506304
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease.
Kankaanpää J; Turunen SP; Moilanen V; Hörkkö S; Remes AM
Neurobiol Dis; 2009 Mar; 33(3):467-72. PubMed ID: 19130885
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
McDowell A; Young IS; Wisdom GB
J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
[TBL] [Abstract][Full Text] [Related]
16. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
Bakalova RA; Hadzhimitova V; Ribarov S
Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against oxLDL and acute coronary syndrome.
Medeiros AM; von Mühlen CA; Gidlund MA; Bodanese R; Gottlieb MG; Bodanese LC
Arq Bras Cardiol; 2010 Jul; 95(1):47-54. PubMed ID: 20563523
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease.
Soto Y; Conde H; Aroche R; Brito V; Luaces P; Nasiff A; Obregón A; Vázquez López AM
Hum Antibodies; 2009; 18(3):109-17. PubMed ID: 19729805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
